Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ: Androgen receptor term inside estrogen receptor-bad cancer of the breast

Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ: Androgen receptor term inside estrogen receptor-bad cancer of the breast

Bieche I, Parfait B, Tozlu S, Lidereau R, Vidaud Yards: Quantitation out-of androgen receptor gene term in the sporadic nipple cancers because of the real-time RT-PCR: research you to definitely MYC are an enthusiastic AR-managed gene. Carcinogenesis. 2001, twenty two (9): 1521-1526. /carcin/twenty-two.9.1521.

Bratthauer GL, Lininger RA, Man YG, Tavassoli FA: Androgen and you can the hormone estrogen receptor mRNA updates into the apocrine carcinomas. Diagn Mol Pathol. 2002, 11 (2): 113-118. 9606-200206000-00008.

Gatalica Z: Immunohistochemical investigation from apocrine breast sores. Consistent more-phrase from androgen receptor followed by the increasing loss of estrogen and you will progesterone receptors in apocrine metaplasia and you can apocrine carcinoma for the situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.

Are J Clin Pathol

Soreide JA, Lea OA, Varhaug JE, Skarstein A, Kvinnsland S: Androgen receptors inside operable breast cancer: reference to most other steroid hormonal receptors, correlations so you’re able to prognostic facts and you can predictive worth to possess effect of additive tamoxifen treatment. Eur J Surg Oncol. 1992, 18 (2): 112-118.

Bayer-Gather IB, Smoller B: Androgen receptors: a great marker to improve sensitiveness having distinguishing breast cancer from inside the facial skin metastasis off unknown pri, thirteen (2): 119-122. /modpathol.3880021.

Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic pastime and medical ramifications. J Clin Oncol. 2000, 18 (5): 1135-1149.

Pang ST, Flores-Morales A, Skoog L, Chuan YC, Nordstedt G, Pousette Good: Controls off matrix metalloproteinase 13 term because of the androgen inside prostate disease. Oncol Agent. 2004, eleven (6): 1187-1192.

Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer. 1984, 54 (11): 2436-2440. -0142(19841201)<2436::AID-CNCR2820541121>3.0.

Schippinger W, Regitnig P, Dandachi N, Wernecke KD, Bauernhofer T, Samonigg H, Moinfar F: Assessment of one’s prognostic need for androgen receptor phrase when you look at the metastatic cancer of the breast. Virchows Arch. 2006, 449 (1): 24-31. /s00428-006-0213-6.

Parker RL, Hunter DG, Lesack DW, Cupples JB, Offer DR, Akbari Yards, Gilks CB: Assessment away from interlaboratory type regarding immunohistochemical commitment out of estrogen receptor condition having fun with a breast cancer tissues microarray. 2002, 117 (5): 723-728. /PEF8-GL6F-YWMC-AG56.

Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, , Garcia-Muniz JL: Examination of matrix metalloproteinases in addition to their inhibitors during the breast cancer. Br J Cancers. 2007, 96 (6): 903-911. /sj.bjc.6603666.

Narita D, Raica Meters, Suciu C, Cimpean A good, Anghel A good: Immunohistochemical phrase of androgen receptor and you will prostate-specific antigen for the breast cancer. Folia Histochem Cytobiol. 2006, 49 (3): 165-172.

Egeblad Yards, Werb Z: The new properties to your matrix metalloproteinases from inside the meet24 mod apk malignant tumors advancement. Nat Rev Cancer tumors. 2002, 2 (3): 161-174. /nrc745.

Turk V, Kos J, Turk B: Cysteine cathepsins (proteases)–towards main stage away from cancers?. Cancer tumors Cell. 2004, 5 (5): 409-410. /S1535-6108(04)00117-5.

Manes S, Llorente Yards, Lacalle RA, Gomez-Mouton C, Kremer L, Mira E, Martinez Ac: The brand new matrix metalloproteinase-9 regulates brand new insulin-like development foundation-caused autocrine effect within the DU-145 carcinoma structure. J Biol Chem. 1999, 274 (11): 6935-6945. /jbc..

Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M: Release of an invasion supporter E-cadherin fragment from the matrilysin and you will stromelysin-step 1. J Phone Sci. 2001, 114 (Pt step 1): 111-118.

Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM: Matrilysin [MMP-7] expression selects having structure with reduced awareness in order to apoptosis. Neoplasia. 2001, step three (6): 459-468. /sj.neo.7900190.


Stetler-Stevenson WG: Matrix metalloproteinases into the angiogenesis: a moving target to have healing input. J Clin Dedicate. 1999, 103 (9): 1237-1241. /JCI6870.

Cornelius La, Nehring LC, Harding Elizabeth, Bolanowski Meters, Welgus HG, Kobayashi DK, Enter RA, Shapiro SD: Matrix metalloproteinases make angiostatin: consequences toward neovascularization. J Immunol. 1998, 161 (12): 6845-6852.

Jiang Y, Goldberg ID, Shi YE: Advanced jobs out-of tissues inhibitors away from metalloproteinases within the disease. Oncogene. 2002, 21 (14): 2245-2252. /sj.onc.1205291.